The role of monocytes in atherosclerotic coronary artery disease

References

• Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, . Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: intimal accumulation of low density lipoprotein and its oxdation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100: 2680–90.
   PubMed Web of Science ®Google Scholar
• Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, . A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Atherosclerosis, American Heart Association. Circulation. 1994;89: 2462–78.
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis—an update. N Engl J Med. 1986;314:488–500.
   PubMed Web of Science ®Google Scholar
• Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulation of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131–8.
   PubMedGoogle Scholar
• Elsheikh E, Uzunel M, He Z, Holgersson J, Nowak G, Sumitran-Holgersson S. Only specific subtype of human peripheral blood monocytes has endothelial-like functional capacity. Blood. 2005;106:2347–55.
   PubMed Web of Science ®Google Scholar
• Shantsila E, Lip GY. Monocytes in acute coronary syndromes. Arterioscler Thromb Vasc Biol. 2009;29:1433–8.
   PubMed Web of Science ®Google Scholar
• Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197–216.
   PubMed Web of Science ®Google Scholar
• Kantari C, Pederzoli-Ribeil M, Witko-Sarsat V. The role of neutrophils and monocytes in innate immunity. Contrib Microbiol. 2008;15:118–46.
   PubMedGoogle Scholar
• Monie TP, Bryant CE, Gay NJ. Activating immunity: lessons from the TLRs and NLRs. Trends Biochem Sci. 2009;34: 553–61.
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001;1:135–45.
   PubMed Web of Science ®Google Scholar
• Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, . Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell. 2007;130:1071–82.
   PubMed Web of Science ®Google Scholar
• Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC, . Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell. 2007;130:906–17.
   PubMed Web of Science ®Google Scholar
• Liu L, Botos I, Wang Y, Leonard JN, Shiloach J, Segal DM, . Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science. 2008;320:379–81.
   PubMed Web of Science ®Google Scholar
• Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature. 2009;458:1191–5.
   PubMed Web of Science ®Google Scholar
• Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, . Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282:2085–8.
   PubMed Web of Science ®Google Scholar
• Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, . Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A. 2004;101:10679–84.
   PubMed Web of Science ®Google Scholar
• Methe H, Kim JO, Kofler S, Weis M, Nabauer M, Koglin J. Expansion of circulating Toll-like receptor 4-positive monocytes in patients with acute coronary syndrome. Circulation. 2005;111:2654–61.
   PubMed Web of Science ®Google Scholar
• Orihara K, Nagata K, Hamasaki S, Oba R, Hirai H, Ishida S, . Time-course of Toll-like receptor 2 expression, as a predictor of recurrence in patients with bacterial infectious diseases. Clin Exp Immunol. 2007;148:260–70.
   PubMed Web of Science ®Google Scholar
• Kajiya T, Orihara K, Hamasaki S, Oba R, Hirai H, Nagata K, . Toll-like receptor 2 expression level on monocytes in patients with viral infections: monitoring infection severity. J Infect. 2008;57:249–59.
   PubMed Web of Science ®Google Scholar
• Mizoguchi E, Orihara K, Hamasaki S, Ishida S, Kataoka T, Ogawa M, . Association between Toll-like receptors and the extent and severity of coronary artery disease in patients with stable angina. Coron Artery Dis. 2007;18:31–8.
   PubMed Web of Science ®Google Scholar
• Kuwahata S, Fujita S, Orihara K, Hamasaki S, Oba R, Hirai H, . High expression level of Toll-like receptor 2 on monocytes is an important risk factor for arteriosclerotic disease. Atherosclerosis. 2010;209:248–54.
   PubMed Web of Science ®Google Scholar
• Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, . Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem. 2002;277:15028–34.
   PubMed Web of Science ®Google Scholar
• Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol. 2006;177: 1272–81.
   PubMed Web of Science ®Google Scholar
• Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol. 2000;164:558–61.
   PubMed Web of Science ®Google Scholar
• Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, . Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med. 2002;195: 99–111.
   PubMed Web of Science ®Google Scholar
• Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol. 2001;167:2887–94.
   PubMed Web of Science ®Google Scholar
• Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor- mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol. 2002;168:5233–9.
   PubMed Web of Science ®Google Scholar
• Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, . The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem. 2001;276:10229–33.
   PubMed Web of Science ®Google Scholar
• Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature. 1998;392:505–9.
   PubMed Web of Science ®Google Scholar
• Devitt A, Parker KG, Ogden CA, Oldreive C, Clay MF, Melville LA, . Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/- mice. J Cell Biol. 2004;67:1161–70.
   Google Scholar
• Frangogiannis NG. The immune system and cardiac repair. Pharmacol Res. 2008;58:88–111.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 2002;109:S81–96.
   PubMed Web of Science ®Google Scholar
• van den Berg R, Haenen GR, van den Berg H, Bast A. Transcription factor NF-kappaB as a potential biomarker for oxidative stress. Br J Nutr. 2001;86 Suppl 1:S121–7.
   Web of Science ®Google Scholar
• Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, . Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996;97:1715–22.
   PubMed Web of Science ®Google Scholar
• Zhao L, Funk CD. Lipoxygenase pathways in atherogenesis. Trends Cardiovasc Med. 2004;14:191–5.
   PubMed Web of Science ®Google Scholar
• Burleigh ME, Babaev VR, Oates JA, Harris RC, Gautam S, Riendeau D, . Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor deficient mice. Circulation. 2002;105:1816–23.
   PubMed Web of Science ®Google Scholar
• Aiello RJ, Bourassa PA, Lindsey S, Weng W, Natoli E, Rollins BJ, . Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 1999;19:1518–25.
   PubMed Web of Science ®Google Scholar
• Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, . A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest. 2001;107:1255–62.
   PubMed Web of Science ®Google Scholar
• Collins RG, Velji R, Guevara NV, Hicks MJ, Chan L, Beaudet AL. P-selectin or intercellular adhesion molecule (ICAM)- 1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med. 2000;191:189–94.
   PubMed Web of Science ®Google Scholar
• Brach MA, Henschler R, Mertelsmann RH, Herrmann F. Regulation of M-CSF expression by M-CSF: role of protein kinase C and transcription factor NF kappa B. Pathobiology. 1991;59:284–8.
   PubMed Web of Science ®Google Scholar
• Tavora FR, Ripple M, Li L, Burke AP. Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques. BMC Cardiovasc Disord. 2009;9:27.
   PubMed Web of Science ®Google Scholar
• Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol. 2001;158:879–91.
   PubMed Web of Science ®Google Scholar
• Hoshi S, Goto M, Koyama N, Nomoto K, Tanaka H. Regulation of vascular smooth muscle cell proliferation by nuclear factor-kappaB and its inhibitor, I-kappaB. J Biol Chem. 2000;275:883–9.
   PubMed Web of Science ®Google Scholar
• Kanda T, Takahashi T. Interleukin-6 and cardiovascular diseases. Jpn Heart J. 2004;45:183–93.
   PubMedGoogle Scholar
• Ikeda U, Ito T, Shimada K. Interleukin-6 and acute coronary syndrome. Clin Cardiol. 2001;24:701–4.
   PubMed Web of Science ®Google Scholar
• Yao L, Huang K, Huang D, Wang J, Guo H, Liao Y. Acute myocardial infarction induced increases in plasma tumor necrosis factor-alpha and interleukin-10 are associated with the activation of poly(ADP-ribose) polymerase of circulating mononuclear cell. Int J Cardiol. 2008;123:366–8.
   PubMed Web of Science ®Google Scholar
• Mestas J, Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med. 2008;18:228–32.
   PubMed Web of Science ®Google Scholar
• Lukacs NW, Strieter RM, Elner V, Evanoff HL, Burdick MD, Kunkel SL. Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions. Blood. 1995;86:2767–73.
   PubMed Web of Science ®Google Scholar
• Lundgren CH, Sawa H, Sobel BE, Fujii S. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy. Circulation. 1994;90:1927–34.
   PubMed Web of Science ®Google Scholar
• Sirpal S. Myeloperoxidase-mediated lipoprotein carbamylation as a mechanistic pathway for atherosclerotic vascular disease. Clin Sci (Lond). 2009;116:681–95.
   PubMed Web of Science ®Google Scholar
• Vasconcelos EM, Degasperi GR, de Oliveira HC, Vercesi AE, de Faria EC, Castilho LN. Reactive oxygen species generation in peripheral blood monocytes and oxidized LDL are increased in hyperlipidemic patients. Clin Biochem. 2009;42: 1222–7.
   PubMed Web of Science ®Google Scholar
• Speidl WS, Toller WG, Kaun C, Weiss TW, Pfaffenberger S, Kastl SP, . Catecholamines potentiate LPS-induced expression of MMP-1 and MMP-9 in human monocytes and in the human monocytic cell line U937: possible implications for peri-operative plaque instability. FASEB J. 2004; 18:603–5.
   PubMed Web of Science ®Google Scholar
• Poitevin S, Garnotel R, Antonicelli F, Gillery P, Nguyen P. Type I collagen induces tissue factor expression and matrix metalloproteinase 9 production in human primary monocytes through a redox-sensitive pathway. J Thromb Haemost. 2008;6:1586–94.
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–26.
   PubMed Web of Science ®Google Scholar
• Irvine KM, Andrews MR, Fernandez-Rojo MA, Schroder K, Burns CJ, Su S, . Colony-stimulating factor-1 (CSF-1) delivers a proatherogenic signal to human macrophages. J Leukoc Biol. 2009;85:278–88.
   PubMed Web of Science ®Google Scholar
• Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A. 1995;92:8264–8.
   PubMed Web of Science ®Google Scholar
• Combadière C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, . Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation. 2008;117:1649–57.
   PubMed Web of Science ®Google Scholar
• Hansson GK, Libby P, Schönbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res. 2002;91:281–91.
   PubMed Web of Science ®Google Scholar
• Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47:C7–12.
   PubMed Web of Science ®Google Scholar
• Weyrich AS, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest. 1995;95:2297–303.
   PubMed Web of Science ®Google Scholar
• van der Wal AC, Das PK, Tigges AJ, Becker AE. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol. 1992;141: 1427–33.
   PubMed Web of Science ®Google Scholar
• Ramos CL, Huo Y, Jung U, Ghosh S, Manka DR, Sarembock IJ, . Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res. 1999;84:1237–44.
   PubMed Web of Science ®Google Scholar
• Gerszten RE, Lim YC, Ding HT, Snapp K, Kansas G, Dichek DA, . Adhesion of monocytes to vascular cell adhesion molecule-1-transduced human endothelial cells: implications for atherogenesis. Circ Res. 1998;82:871–8.
   PubMed Web of Science ®Google Scholar
• Huo Y, Weber C, Forlow SB, Sperandio M, Thatte J, Mack M, . The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J Clin Invest. 2001;108: 1307–14.
   PubMed Web of Science ®Google Scholar
• von Hundelshausen P, Koenen RR, Sack M, Mause SF, Adriaens W, Proudfoot AE, . Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood. 2005;105:924–30.
   PubMed Web of Science ®Google Scholar
• Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, . Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest. 2007;117:195–205.
   PubMed Web of Science ®Google Scholar
• Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, . Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest. 2007;117:185–94.
   PubMed Web of Science ®Google Scholar
• Apostolakis S, Lip GY, Shantsila E. Monocytes in heart failure: Relationship to a deteriorating immune overreaction or a desperate attempt for tissue repair? Cardiovasc Res. 2010; 85:649–60.
   PubMed Web of Science ®Google Scholar
• Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979;76: 333–7.
   PubMed Web of Science ®Google Scholar
• Krieger M. The other side of scavenger receptors: pattern recognition for host defense. Curr Opin Lipidol. 1997;8: 275–80.
   PubMed Web of Science ®Google Scholar
• Devitt A, Gregory CD. Innate immune mechanisms in the resolution of inflammation. In: Rossi AG, Sawatzky DA. Progress in inflammation: the resolution of inflammation. Basel: Birkhauser Verlag; 2008. p. 39–56.
   Google Scholar
• de Winther MP, Gijbels MJ, van Dijk KW, van Gorp PJ, Suzuki H, Kodama T, . Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice. Atherosclerosis. 1999;144:315–21.
   PubMed Web of Science ®Google Scholar
• Dansky HM, Charlton SA, Sikes JL, Heath SC, Simantov R, Levin LF, . Genetic background determines the extent of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 1999;19:1960–8.
   PubMed Web of Science ®Google Scholar
• Teupser D, Stein O, Burkhardt R, Nebendahl K, Stein Y, Thiery J. Scavenger receptor activity is increased in macrophages from rabbits with low atherosclerotic response: studies in normocholesterolemic high and low atherosclerotic response rabbits. Arterioscler Thromb Vasc Biol. 1999;19: 1299–305.
   PubMed Web of Science ®Google Scholar
• Silverstein RL, Febbraio M. CD36 and atherosclerosis. Curr Opin Lipidol. 2000;11:483–91.
   PubMed Web of Science ®Google Scholar
• Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, . Targeted disruption of the Class B scavenger receptor, CD36, protects against atherosclerotic lesion development in mice. J Clin Invest. 2000;105:1049–56.
   PubMed Web of Science ®Google Scholar
• Silverstein RL. Inflammation, atherosclerosis, and arterial thrombosis: Role of the scavenger receptor CD36. Cleve Clin J Medicine. 2009;76:S27–30.
   PubMedGoogle Scholar
• Febbraio M, Guy E, Silverstein RL. Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. Arterioscler Thromb Vasc Biol. 2004; 24:2333–8.
   PubMed Web of Science ®Google Scholar
• Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci U S A. 1997;94:12610–5.
   PubMed Web of Science ®Google Scholar
• Braun A, Trigatti BL, Post MJ, Sato K, Simons M, Edelberg JM, . Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res. 2002;90:270–6.
   PubMed Web of Science ®Google Scholar
• Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, . Atherosclerotic plaque progression and vulnerability to rupture angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005;25: 2054–61.
   PubMed Web of Science ®Google Scholar
• Moulton KS. Plaque angiogenesis: its functions and regulation. Cold Spring Harbor Symp Quant Biol. 2002;67: 471–82.
   PubMedGoogle Scholar
• Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn Gelpke MD, . Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol. 2008;51:1258–65.
   PubMed Web of Science ®Google Scholar
• Gessi S, Fogli E, Sacchetto V, Merighi S, Varani K, Preti D, . Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells. Arterioscler Thromb Vasc Biol. 2010;30:90–7.
   PubMed Web of Science ®Google Scholar
• Fong GH. Mechanisms of adaptive angiogenesis to tissue hypoxia. Angiogenesis. 2008;11:121–40.
   PubMed Web of Science ®Google Scholar
• Lambert JM, Lopez EF, Lindsey ML. Macrophage roles following myocardial infarction. Int J Cardiol. 2008;130: 147–58.
   PubMed Web of Science ®Google Scholar
• Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, . Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A. 2003; 100:4736–41.
   PubMed Web of Science ®Google Scholar
• Ribatti D, Levi-Schaffer F, Kovanen PT. Inflammatory angiogenesis in atherogenesis—a double-edged sword. Ann Med. 2008;40:606–21.
   PubMed Web of Science ®Google Scholar
• Murdoch C, Tazzyman S, Webster S, Lewis CE. Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J Immunol. 2007;178:7405–11.
   PubMed Web of Science ®Google Scholar
• Shantsila E, Lip GY. The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms. Thromb Haemost. 2009;102:916–24.
   PubMed Web of Science ®Google Scholar
• Simon DI, Ezratty AM, Francis SA, Rennke H, Loscalzo J. Fibrin(ogen) is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): a nonplasmin fibrinolytic pathway. Blood. 1993;82:2414–22.
   PubMed Web of Science ®Google Scholar
• Arber N, Berliner S, Pras E, Arber L, Fishelson Z, Kahn Y, . Heterotypic leukocyte aggregation in the peripheral blood of patients with leukemia, inflammation and stress. Nouv Rev Fr Hematol. 1991;33:251–5.
   PubMedGoogle Scholar
• Kaplar M, Kappelmayer J, Veszpremi A, Szabo K, Udvardy M. The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy. Platelets. 2001;12:419–22.
   PubMed Web of Science ®Google Scholar
• Danenberg HD, Kantak N, Grad E, Swaminathan RV, Lotan C, Edelman ER. C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy. Eur J Haematol. 2007; 78:246–52.
   PubMed Web of Science ®Google Scholar
• Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC, . Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol. 1998;31:352–8.
   PubMed Web of Science ®Google Scholar
• Brambilla M, Camera M, Colnago D, Marenzi G, De Metrio M, Giesen PL, . Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates. Arterioscler Thromb Vasc Biol. 2008;28:947–53.
   PubMed Web of Science ®Google Scholar
• Maekawa Y, Anzai T, Yoshikawa T, Asakura Y, Takahashi T, Ishikawa S, . Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol. 2002;39:241–6.
   PubMed Web of Science ®Google Scholar
• Hojo Y, Ikeda U, Zhu Y, Okada M, Ueno S, Arakawa H, . Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol. 2000;35:968–73.
   PubMed Web of Science ®Google Scholar
• Iwama H, Uemura S, Naya N, Imagawa K, Takemoto Y, Asai O, . Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction. J Am Coll Cardiol. 2006;47:1559–67.
   PubMed Web of Science ®Google Scholar
• Tsujioka H, Imanishi T, Ikejima H, Kuroi A, Takarada S, Tanimoto T, . Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol. 2009;54:130–8.
   PubMed Web of Science ®Google Scholar
• Bruno S, Bussolati B, Scacciatella P, Marra S, Sanavio F, Tarella C, . Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarction. Cytokine. 2006;34:56–65.
   PubMed Web of Science ®Google Scholar
• Dresske B, El Mokhtari NE, Ungefroren H, Ruhnke M, Plate V, Janssen D, . Multipotent cells of monocytic origin improve damaged heart function. Am J Transplant. 2006;6:947–58.
   PubMed Web of Science ®Google Scholar
• Satoh M, Shimoda Y, Akatsu T, Ishikawa Y, Minami Y, Nakamura M. Elevated circulating levels of heat shock protein 70 are related to systemic inflammatory reaction through monocyte Toll signal in patients with heart failure after acute myocardial infarction. Eur J Heart Fail. 2006;8:810–5.
   PubMed Web of Science ®Google Scholar
• de Lemos JA, Morrow DA, Blazing MA, Jarolim P, Wiviott SD, Sabatine MS, . Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial. J Am Coll Cardiol. 2007;50: 2117–24.
   PubMed Web of Science ®Google Scholar
• Satoh M, Shimoda Y, Maesawa C, Akatsu T, Ishikawa Y, Minami Y, . Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. Int J Cardiol. 2006;109:226–34.
   PubMed Web of Science ®Google Scholar
• Sheu JJ, Chang LT, Chiang CH, Youssef AA, Wu CJ, Lee FY, . Prognostic value of activated toll-like receptor-4 in monocytes following acute myocardial infarction. Int Heart J. 2008;49:1–11.
   PubMed Web of Science ®Google Scholar
• Dahl CP, Gullestad L, Fevang B, Holm AM, Landrø L, Vinge LE, . Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure. Eur J Heart Fail. 2008;10:352–9.
   PubMed Web of Science ®Google Scholar
• Satoh M, Iwasaka J, Nakamura M, Akatsu T, Shimoda Y, Hiramori K. Increased expression of tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure. Eur J Heart Fail. 2004;6: 869–75.
   PubMed Web of Science ®Google Scholar